Aptevo Therapeutics Inc.

APVO ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
424B4	Sep 3, 2026	424B4
8-K	Sep 3, 2026	8-K
EFFECT	Sep 2, 2026
DEF 14A	Aug 31, 2026	DEF 14A
D	Aug 26, 2026
PRE 14A	Aug 21, 2026	PRE 14A
S-1	Aug 21, 2026	S-1
8-K	Aug 21, 2026	8-K
SCHEDULE 13G/A	Aug 14, 2026
10-Q	Aug 14, 2026	10-Q
8-K	Aug 14, 2026	8-K
8-K	Aug 13, 2026	8-K
4	Aug 10, 2026	4
4	Aug 10, 2026	4
4	Aug 10, 2026	4
4	Aug 10, 2026	4
4	Aug 10, 2026	4
4	Aug 10, 2026	4
4	Aug 10, 2026	4
4	Aug 10, 2026	4
4	Aug 10, 2026	4
4	Aug 10, 2026	4
DEF 14A	Jul 31, 2026	DEF 14A
ARS	Jul 31, 2026	ARS
8-K	Jul 27, 2026	8-K

← Newer Page 1 of 30 · 729 filings Older →